Supplementary Material for: Duchenne and Becker Muscular Dystrophies’ Prevalence in MD STARnet Surveillance Sites: An Examination of Racial and Ethnic Differences

Introduction: Previous studies indicated variability in the prevalence of Duchenne and Becker muscular dystrophies (DBMD) by racial/ethnic groups. The Centers for Disease Control and Prevention’s (CDC) Muscular Dystrophy Surveillance, Tracking, and Research network (MD STARnet) conducts muscular dys...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Zhang, Y., Mann, J.R., James, K.A., McDermott, S., Conway, K.M., Paramsothy, P., Smith, T., Cai, B., The MD STARnet
Format: Dataset
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Zhang, Y.
Mann, J.R.
James, K.A.
McDermott, S.
Conway, K.M.
Paramsothy, P.
Smith, T.
Cai, B.
The MD STARnet
description Introduction: Previous studies indicated variability in the prevalence of Duchenne and Becker muscular dystrophies (DBMD) by racial/ethnic groups. The Centers for Disease Control and Prevention’s (CDC) Muscular Dystrophy Surveillance, Tracking, and Research network (MD STARnet) conducts muscular dystrophy surveillance in multiple geographic areas of the USA and continues to enroll new cases. This provides an opportunity to continue investigating differences in DBMD prevalence by race and ethnicity and to compare the impact of using varying approaches for estimating prevalence. Objective: To estimate overall and race/ethnicity-specific prevalence of DBMD among males aged 5–9 years and compare the performance of three prevalence estimation methods. Methods: The overall and race/ethnicity-specific 5-year period prevalence rates were estimated with MD STARnet data using three methods. Method 1 used the median of 5-year prevalence, and methods 2 and 3 calculated prevalence directly with different birth cohorts. To compare prevalence between racial/ethnic groups, Poisson modeling was used to estimate prevalence ratios (PRs) with non-Hispanic (NH) whites as the referent group. Comparison between methods was also conducted. Results: In the final population-based sample of 1,164 DBMD males, the overall 5-year prevalence for DBMD among 5–9 years of age ranged from 1.92 to 2.48 per 10,000 males, 0.74–1.26 for NH blacks, 1.78–2.26 for NH whites, 2.24–4.02 for Hispanics, and 0.61–1.83 for NH American Indian or Alaska Native and Asian or Native Hawaiian or Pacific Islander (AIAN/API). The PRs for NH blacks/NH whites, Hispanics/NH whites, and NH AIAN/API/NH whites were 0.46 (95% CI: 0.36–0.59), 1.37 (1.17–1.61), and 0.61 (0.40–0.93), respectively. Conclusions: In males aged 5–9 years, compared to the prevalence of DBMD in NH whites, prevalence in NH blacks and NH AIAN/API was lower and higher in Hispanics. All methods produced similar prevalence estimates; however, method 1 produced narrower confidence intervals and method 2 produced fewer zero prevalence estimates than the other two methods.
doi_str_mv 10.6084/m9.figshare.13622420
format Dataset
fullrecord <record><control><sourceid>datacite_PQ8</sourceid><recordid>TN_cdi_datacite_primary_10_6084_m9_figshare_13622420</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_6084_m9_figshare_13622420</sourcerecordid><originalsourceid>FETCH-LOGICAL-d910-3db002a38219f0ddf414df1543dd44bdd776bef45cf8498f0b852c5b58b16b543</originalsourceid><addsrcrecordid>eNo1kE1OwzAUhLNhgQo3YPEu0GInTpp0V5ryI7UCNd1Hjv1MLBInsp2K7rgGe07Wk9AIuprFjGZGXxDcUTJLSMru22ym9LurucUZjZIwZCG5Dn6Koe8bbNF4bo-w5R6t5g2ozi4gH0SNxiBwI-EBxQda2A5ODA23kB-dt11fa3Snr294s3jgDRqBoA1scyj2y51BD8VgD6ibho9WoT26BSwNrD95qw33ujPQKdhxMc6OQ2tfGy0g10qhHQvdTXCleOPw9l8nwf5xvV89TzevTy-r5WYqM0qmkawICXmUhjRTRErFKJOKxiySkrFKyvk8qVCxWKiUZakiVRqHIq7itKJJdY5NAvZXK7k_3_FY9la3ZywlJeXIsGyz8sKwvDCMfgE75XFq</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>dataset</recordtype></control><display><type>dataset</type><title>Supplementary Material for: Duchenne and Becker Muscular Dystrophies’ Prevalence in MD STARnet Surveillance Sites: An Examination of Racial and Ethnic Differences</title><source>DataCite</source><creator>Zhang, Y. ; Mann, J.R. ; James, K.A. ; McDermott, S. ; Conway, K.M. ; Paramsothy, P. ; Smith, T. ; Cai, B. ; The MD STARnet</creator><creatorcontrib>Zhang, Y. ; Mann, J.R. ; James, K.A. ; McDermott, S. ; Conway, K.M. ; Paramsothy, P. ; Smith, T. ; Cai, B. ; The MD STARnet</creatorcontrib><description>Introduction: Previous studies indicated variability in the prevalence of Duchenne and Becker muscular dystrophies (DBMD) by racial/ethnic groups. The Centers for Disease Control and Prevention’s (CDC) Muscular Dystrophy Surveillance, Tracking, and Research network (MD STARnet) conducts muscular dystrophy surveillance in multiple geographic areas of the USA and continues to enroll new cases. This provides an opportunity to continue investigating differences in DBMD prevalence by race and ethnicity and to compare the impact of using varying approaches for estimating prevalence. Objective: To estimate overall and race/ethnicity-specific prevalence of DBMD among males aged 5–9 years and compare the performance of three prevalence estimation methods. Methods: The overall and race/ethnicity-specific 5-year period prevalence rates were estimated with MD STARnet data using three methods. Method 1 used the median of 5-year prevalence, and methods 2 and 3 calculated prevalence directly with different birth cohorts. To compare prevalence between racial/ethnic groups, Poisson modeling was used to estimate prevalence ratios (PRs) with non-Hispanic (NH) whites as the referent group. Comparison between methods was also conducted. Results: In the final population-based sample of 1,164 DBMD males, the overall 5-year prevalence for DBMD among 5–9 years of age ranged from 1.92 to 2.48 per 10,000 males, 0.74–1.26 for NH blacks, 1.78–2.26 for NH whites, 2.24–4.02 for Hispanics, and 0.61–1.83 for NH American Indian or Alaska Native and Asian or Native Hawaiian or Pacific Islander (AIAN/API). The PRs for NH blacks/NH whites, Hispanics/NH whites, and NH AIAN/API/NH whites were 0.46 (95% CI: 0.36–0.59), 1.37 (1.17–1.61), and 0.61 (0.40–0.93), respectively. Conclusions: In males aged 5–9 years, compared to the prevalence of DBMD in NH whites, prevalence in NH blacks and NH AIAN/API was lower and higher in Hispanics. All methods produced similar prevalence estimates; however, method 1 produced narrower confidence intervals and method 2 produced fewer zero prevalence estimates than the other two methods.</description><identifier>DOI: 10.6084/m9.figshare.13622420</identifier><language>eng</language><publisher>Karger Publishers</publisher><subject>Medicine</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>780,1894</link.rule.ids><linktorsrc>$$Uhttps://commons.datacite.org/doi.org/10.6084/m9.figshare.13622420$$EView_record_in_DataCite.org$$FView_record_in_$$GDataCite.org$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Zhang, Y.</creatorcontrib><creatorcontrib>Mann, J.R.</creatorcontrib><creatorcontrib>James, K.A.</creatorcontrib><creatorcontrib>McDermott, S.</creatorcontrib><creatorcontrib>Conway, K.M.</creatorcontrib><creatorcontrib>Paramsothy, P.</creatorcontrib><creatorcontrib>Smith, T.</creatorcontrib><creatorcontrib>Cai, B.</creatorcontrib><creatorcontrib>The MD STARnet</creatorcontrib><title>Supplementary Material for: Duchenne and Becker Muscular Dystrophies’ Prevalence in MD STARnet Surveillance Sites: An Examination of Racial and Ethnic Differences</title><description>Introduction: Previous studies indicated variability in the prevalence of Duchenne and Becker muscular dystrophies (DBMD) by racial/ethnic groups. The Centers for Disease Control and Prevention’s (CDC) Muscular Dystrophy Surveillance, Tracking, and Research network (MD STARnet) conducts muscular dystrophy surveillance in multiple geographic areas of the USA and continues to enroll new cases. This provides an opportunity to continue investigating differences in DBMD prevalence by race and ethnicity and to compare the impact of using varying approaches for estimating prevalence. Objective: To estimate overall and race/ethnicity-specific prevalence of DBMD among males aged 5–9 years and compare the performance of three prevalence estimation methods. Methods: The overall and race/ethnicity-specific 5-year period prevalence rates were estimated with MD STARnet data using three methods. Method 1 used the median of 5-year prevalence, and methods 2 and 3 calculated prevalence directly with different birth cohorts. To compare prevalence between racial/ethnic groups, Poisson modeling was used to estimate prevalence ratios (PRs) with non-Hispanic (NH) whites as the referent group. Comparison between methods was also conducted. Results: In the final population-based sample of 1,164 DBMD males, the overall 5-year prevalence for DBMD among 5–9 years of age ranged from 1.92 to 2.48 per 10,000 males, 0.74–1.26 for NH blacks, 1.78–2.26 for NH whites, 2.24–4.02 for Hispanics, and 0.61–1.83 for NH American Indian or Alaska Native and Asian or Native Hawaiian or Pacific Islander (AIAN/API). The PRs for NH blacks/NH whites, Hispanics/NH whites, and NH AIAN/API/NH whites were 0.46 (95% CI: 0.36–0.59), 1.37 (1.17–1.61), and 0.61 (0.40–0.93), respectively. Conclusions: In males aged 5–9 years, compared to the prevalence of DBMD in NH whites, prevalence in NH blacks and NH AIAN/API was lower and higher in Hispanics. All methods produced similar prevalence estimates; however, method 1 produced narrower confidence intervals and method 2 produced fewer zero prevalence estimates than the other two methods.</description><subject>Medicine</subject><fulltext>true</fulltext><rsrctype>dataset</rsrctype><creationdate>2021</creationdate><recordtype>dataset</recordtype><sourceid>PQ8</sourceid><recordid>eNo1kE1OwzAUhLNhgQo3YPEu0GInTpp0V5ryI7UCNd1Hjv1MLBInsp2K7rgGe07Wk9AIuprFjGZGXxDcUTJLSMru22ym9LurucUZjZIwZCG5Dn6Koe8bbNF4bo-w5R6t5g2ozi4gH0SNxiBwI-EBxQda2A5ODA23kB-dt11fa3Snr294s3jgDRqBoA1scyj2y51BD8VgD6ibho9WoT26BSwNrD95qw33ujPQKdhxMc6OQ2tfGy0g10qhHQvdTXCleOPw9l8nwf5xvV89TzevTy-r5WYqM0qmkawICXmUhjRTRErFKJOKxiySkrFKyvk8qVCxWKiUZakiVRqHIq7itKJJdY5NAvZXK7k_3_FY9la3ZywlJeXIsGyz8sKwvDCMfgE75XFq</recordid><startdate>20210121</startdate><enddate>20210121</enddate><creator>Zhang, Y.</creator><creator>Mann, J.R.</creator><creator>James, K.A.</creator><creator>McDermott, S.</creator><creator>Conway, K.M.</creator><creator>Paramsothy, P.</creator><creator>Smith, T.</creator><creator>Cai, B.</creator><creator>The MD STARnet</creator><general>Karger Publishers</general><scope>DYCCY</scope><scope>PQ8</scope></search><sort><creationdate>20210121</creationdate><title>Supplementary Material for: Duchenne and Becker Muscular Dystrophies’ Prevalence in MD STARnet Surveillance Sites: An Examination of Racial and Ethnic Differences</title><author>Zhang, Y. ; Mann, J.R. ; James, K.A. ; McDermott, S. ; Conway, K.M. ; Paramsothy, P. ; Smith, T. ; Cai, B. ; The MD STARnet</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-d910-3db002a38219f0ddf414df1543dd44bdd776bef45cf8498f0b852c5b58b16b543</frbrgroupid><rsrctype>datasets</rsrctype><prefilter>datasets</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Medicine</topic><toplevel>online_resources</toplevel><creatorcontrib>Zhang, Y.</creatorcontrib><creatorcontrib>Mann, J.R.</creatorcontrib><creatorcontrib>James, K.A.</creatorcontrib><creatorcontrib>McDermott, S.</creatorcontrib><creatorcontrib>Conway, K.M.</creatorcontrib><creatorcontrib>Paramsothy, P.</creatorcontrib><creatorcontrib>Smith, T.</creatorcontrib><creatorcontrib>Cai, B.</creatorcontrib><creatorcontrib>The MD STARnet</creatorcontrib><collection>DataCite (Open Access)</collection><collection>DataCite</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Zhang, Y.</au><au>Mann, J.R.</au><au>James, K.A.</au><au>McDermott, S.</au><au>Conway, K.M.</au><au>Paramsothy, P.</au><au>Smith, T.</au><au>Cai, B.</au><au>The MD STARnet</au><format>book</format><genre>unknown</genre><ristype>DATA</ristype><title>Supplementary Material for: Duchenne and Becker Muscular Dystrophies’ Prevalence in MD STARnet Surveillance Sites: An Examination of Racial and Ethnic Differences</title><date>2021-01-21</date><risdate>2021</risdate><abstract>Introduction: Previous studies indicated variability in the prevalence of Duchenne and Becker muscular dystrophies (DBMD) by racial/ethnic groups. The Centers for Disease Control and Prevention’s (CDC) Muscular Dystrophy Surveillance, Tracking, and Research network (MD STARnet) conducts muscular dystrophy surveillance in multiple geographic areas of the USA and continues to enroll new cases. This provides an opportunity to continue investigating differences in DBMD prevalence by race and ethnicity and to compare the impact of using varying approaches for estimating prevalence. Objective: To estimate overall and race/ethnicity-specific prevalence of DBMD among males aged 5–9 years and compare the performance of three prevalence estimation methods. Methods: The overall and race/ethnicity-specific 5-year period prevalence rates were estimated with MD STARnet data using three methods. Method 1 used the median of 5-year prevalence, and methods 2 and 3 calculated prevalence directly with different birth cohorts. To compare prevalence between racial/ethnic groups, Poisson modeling was used to estimate prevalence ratios (PRs) with non-Hispanic (NH) whites as the referent group. Comparison between methods was also conducted. Results: In the final population-based sample of 1,164 DBMD males, the overall 5-year prevalence for DBMD among 5–9 years of age ranged from 1.92 to 2.48 per 10,000 males, 0.74–1.26 for NH blacks, 1.78–2.26 for NH whites, 2.24–4.02 for Hispanics, and 0.61–1.83 for NH American Indian or Alaska Native and Asian or Native Hawaiian or Pacific Islander (AIAN/API). The PRs for NH blacks/NH whites, Hispanics/NH whites, and NH AIAN/API/NH whites were 0.46 (95% CI: 0.36–0.59), 1.37 (1.17–1.61), and 0.61 (0.40–0.93), respectively. Conclusions: In males aged 5–9 years, compared to the prevalence of DBMD in NH whites, prevalence in NH blacks and NH AIAN/API was lower and higher in Hispanics. All methods produced similar prevalence estimates; however, method 1 produced narrower confidence intervals and method 2 produced fewer zero prevalence estimates than the other two methods.</abstract><pub>Karger Publishers</pub><doi>10.6084/m9.figshare.13622420</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier DOI: 10.6084/m9.figshare.13622420
ispartof
issn
language eng
recordid cdi_datacite_primary_10_6084_m9_figshare_13622420
source DataCite
subjects Medicine
title Supplementary Material for: Duchenne and Becker Muscular Dystrophies’ Prevalence in MD STARnet Surveillance Sites: An Examination of Racial and Ethnic Differences
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T09%3A36%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-datacite_PQ8&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.au=Zhang,%20Y.&rft.date=2021-01-21&rft_id=info:doi/10.6084/m9.figshare.13622420&rft_dat=%3Cdatacite_PQ8%3E10_6084_m9_figshare_13622420%3C/datacite_PQ8%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true